Virax Biolabs Group Limited (VRAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
BioCity Glasgow
Lanarkshire, SC ML1 5UH
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 20 7788 7414
Website
Sector
Healthcare
Industry
Biotechnology
Employees
19
First IPO Date
July 21, 2022
| Name | Title | Pay | Year Born |
| James Foster | Chairman, Chief Executive Officer & Principal Accounting Officer | 477,452 | 1985 |
| Nigel McCracken | Chief Operating Officer & Director | 485,424 | 1965 |
| Clement Monteil | Head of Scientific Research & Development | 0 | N/A |
| Lily Fu | Head of Supply Chain | 0 | N/A |
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.